Conclusions: High-or moderate-intensity statin therapy at 1 year after revascularization for CLTI is associated with higher long-term survival. However, a significant proportion of these patients had their statin stopped or intensity of therapy decreased within the first postoperative year, resulting in a loss of this survival difference. These results demonstrate the importance not only of discharging this population on highor moderate-intensity statin therapy but also of maintaining this therapy postoperatively.
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Objective: Peripheral artery disease is a common comorbidity in patients with end-stage renal disease, but there is a paucity of data comparing outcomes of endovascular and open revascularization in this group of patients. In this study, we examined perioperative outcomes of lower extremity endovascular (LEE) revascularization and open lower extremity bypass (LEB) in patients on dialysis.
Methods: Patients on dialysis and undergoing LEE revascularization and LEB from 2011 to 2015 were identified in the American College of Surgeons National Surgical Quality Improvement Program targeted vascular data set. Patients' demographics, comorbidities, anatomic features, and perioperative outcomes were compared between LEE and LEB procedures.
Results: From 2011 to 2015, there were 1157 lower extremity revascularizations performed in dialysis patients. In this group, 608 were LEE (53%) and 549 were LEB (47%) procedures. Demographics such as age, sex, race, and body mass index were similar between the two groups (P > .05). Patients undergoing open and endovascular procedures had similar rate of comorbidities of hypertension, smoking, congestive heart failure, diabetes, chronic obstructive pulmonary disease, and bleeding disorders. Only 50 (4%) procedures were done emergently, and there was a similar rate in the two groups. A majority of the procedures (n ¼ 1033 [89.7%]) were done for critical limb ischemia. Preoperative aspirin and beta blocker use was higher in the LEE group, and statin use was similar between the two groups. Table I compares postoperative outcomes on univariate analysis between the two groups. On risk-adjusted multivariate analysis (Table II) , LEB was associated with a lower rate of major amputation but a higher rate of postoperative bleeding and wound complications. Thirty-day mortality and cardiovascular morbidity were similar between the two groups.
Conclusions: In dialysis patients, LEB is associated with a lower risk of major limb amputation but a higher rate of postoperative wound complications and bleeding compared with LEE revascularization. Cardiovascular complications, 30-day mortality, and reinterventions were similar in the two groups. In dialysis patients who are a good surgical risk and with an appropriate target, lower extremity bypass procedures should be strongly considered for infrainguinal revascularization to achieve better limb salvage. Longer term outcomes comparing the two types of procedures are needed. (OR, 17; ER, 64) . The most common etiology changed from mediastinal fibrosis (49%) to indwelling catheters (53%) over time for OR and remained stable for ER (Table) . OR followed attempted/failed ER more frequently in period II than in period I (76.5% vs 35%; P ¼ .09), with concomitant increase in ER for Doty type IV SVC occlusion (12.5% vs 0%; P ¼ .08). Use of spiral saphenous vein as graft conduit decreased significantly in period II compared with period I (17.5% vs 57%; P ¼ .05), with increase in femoral vein and polytetrafluoroethylene as well as elective use of covered stents during ER (26.5% vs 0%; P ¼ .01). Periprocedural morbidity and mortality remained unchanged over time for OR (16% vs 12% and 0% vs 0%, respectively) and ER (4.2% vs 3% and 0% vs 0%, respectively). Mean follow-up was 4.9 years (range, 0.1-17.5 years) for OR and 3.2 years (range, 0.1-12.4 years) for ER. Incidence of secondary interventions (131 procedures in 51 patients, average 2.5 per patient) during follow-up was lower for OR compared with ER (1.7 vs 2.9 per patient; P ¼ .06), remained stable for OR (24% and 24% patients, respectively), but decreased for ER (38% vs 56% patients, respectively; P ¼ .2). Overall primary, assisted primary, and secondary patency rates were 61%, 78%, and 91% at 5 years after OR and 54%, 88%, and 94% at 3 years after ER, significantly better in period II vs period I for both types of repair (OR: 76% vs 55%, 94% vs 76%, and 100% vs 83%, respectively [P ¼ .02]; ER: 56% vs 50%, 94% vs 79%, and 97% vs 87% ,respectively [P ¼ .02]).
Conclusions: Open surgical reconstruction for benign SVC syndrome is now rarely performed but is still associated with satisfactory, durable results in spite of increasing complexity. It remains an excellent option for patients who are not suitable for or who fail to respond to endovascular intervention.
Table.
Clinical presentation, procedural details, and early and late outcomes in 143 patients undergoing intervention for benign superior vena cava (SVC) syndrome, divided by temporal periods (1982-2004 and 2005-2017) Objective: The objective of this study was to describe the mortality effect of utilization of local or regional anesthesia in lieu of general anesthesia in the endovascular repair of ruptured abdominal aortic aneurysms (rAAAs).
Methods: Our study included patients from the 2007 to 2015 American College of Surgeons National Surgical Quality Improvement Program who underwent endovascular repair of rAAAs. Patients who underwent a concomitant procedure that would necessitate use of general anesthesia were excluded from analysis. Propensity score matching techniques were used to compare the 30-day postoperative outcomes of patients who underwent repair under locoregional vs general anesthesia.
Comparison of outcomes of the matched cohort was performed using McNemar c 2 tests. Results: A total of 1382 endovascular rAAA repairs were available for analysis. Of these patients, 132 (9.5%) underwent repair under locoregional anesthesia, whereas 1250 (90.5%) underwent repair under general anesthesia. Our propensity score algorithm yielded a cohort of 130 general anesthesia patients and 130 locoregional anesthesia patients who were well matched for all known patient and procedure characteristics.
Comparison of the matched cohort demonstrated greater 30-day postoperative morbidity (23.9% vs 12.3%; P ¼ .03) and mortality (30% vs 14.6%; P ¼ .002) for general anesthesia patients compared with locoregional anesthesia patients.
Conclusions: Utilization of locoregional rather than general anesthesia during endovascular repair of rAAA is associated with a significant 30-day postoperative survival advantage. Objective: It has been proposed that only a small percentage of patients with internal carotid artery occlusion (ICAO) have clinical symptoms. Our aim was to explore the clinical presentation, risk factors, and ultrasound characteristics in a large cohort of patients with ICAO.
Methods: We prospectively recorded atherosclerotic risk factors, the symptoms at the time of diagnosis, and the degree of contralateral internal carotid artery (ICA) stenosis during the period 1987 to 2017 and coagulation status for the years 2014 to 2017 for ICAO patients. We classified the plaques as echolucent (I-II) or echogenic (III-IV-V) according to the Gray-Weale classification.
Results: A total of 274 patients (82.5% male; mean age, 65.6 6 9.7 years) with 279 ICAOs were included. In 132 patients (48.2%), the right ICA was occluded, whereas 5 patients (1.8%) presented with bilateral ICA occlusion; 81 (29.6%) of the patients had diabetes mellitus, 251 (91.6%) had hypertension, 126 (46.0%) reported history of coronary artery disease, and 230 (83.9%) were ex-smokers or current smokers, whereas hyperlipidemia was prevalent in 229 (83.6%) of the study sample. In a recent series of 25 patients with ICAO, 15 (60%) were found to be positive for antiphospholipid syndrome. A total of 192 patients (70%) with ICAO had disease in at least one additional vascular bed (aorta, coronary or lower limb arteries).
Conclusions: Patients with ICAO have significant atherosclerotic risk factors, are mainly symptomatic at the time of diagnosis, and have advanced disease in other arterial beds as well as coagulation disorders. Plaque echolucency is associated with occlusion of the ICA, indicating a more aggressive plaque type. These data suggest that increased attention is needed in the management of patients with high-grade ICA stenosis, especially with echolucent plaques, both medically and interventionally, to avoid progression to total occlusion, which contrary to recent reports is not a benign condition.
